Literature DB >> 12929020

Colonoscopy and multidetector-array computed-tomographic colonography: detection rates and feasibility.

B Ginnerup Pedersen1, T E M Christiansen, N C Bjerregaard, K Ljungmann, S Laurberg.   

Abstract

BACKGROUND AND STUDY AIMS: Computed-tomographic (CT) colonography has been introduced as a minimally invasive colon examination for the detection of colorectal neoplasms. The aim of this study was to compare the performance characteristics of multidetector-array CT colonography (MDCTC) and conventional colonoscopy in a prospective, blinded design. PATIENTS AND METHODS: Sixty-six symptomatic patients, 75 patients undergoing polyp and cancer surveillance, and seven patients undergoing preoperative colonoscopy due to colorectal cancer (CRC) were examined with MDCTC and subsequent colonoscopy. The gold standard was colonoscopy. If MDCTC was positive and the first-pass colonoscopy was negative, a second-pass colonoscopy served as the gold standard.
RESULTS: Complete colonoscopy was achieved in 91% of the patients, while technically satisfying MDCTC was obtained in 76% of the patients (P < 0.01), insufficient air distension in the sigmoid colon being the main problem. MDCTC and colonoscopy both detected all 11 carcinomas. Overall detection rates for polypoid lesions 6 mm or larger in size were 81% (95% CI, 70% to 90%) for MDCTC and 87% (95% CI, 77% to 94%) for colonoscopy (P = 0.52), with a significant difference with regard to the detection of polyps 6-9 mm in size in favor of colonoscopy (P = 0.008). The specificity of MDCTC at a 6-mm level was 97% (95% CI, 92% to 99%).
CONCLUSIONS: MDCTC and colonoscopy show equal overall sensitivity for the detection of polypoid lesions 6 mm or larger in size, but more patients are inadequately examined when MDCTC is used.

Entities:  

Mesh:

Year:  2003        PMID: 12929020     DOI: 10.1055/s-2003-41584

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  10 in total

1.  Screening for colon cancer.

Authors:  J P Heiken
Journal:  Cancer Imaging       Date:  2006-10-31       Impact factor: 3.909

Review 2.  Colonoscopy vs CT colonography to screen for colorectal neoplasia in average-risk patients.

Authors:  J M Hardacre; J L Ponsky; M E Baker
Journal:  Surg Endosc       Date:  2005-03       Impact factor: 4.584

Review 3.  Current status of CT colonography.

Authors:  Suzanne M Frentz; Ronald M Summers
Journal:  Acad Radiol       Date:  2006-12       Impact factor: 3.173

4.  Computed Tomographic (CT) Colonography for Colorectal Cancer Screening: An Evidence-Based Analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2009-09-01

5.  Screening methods for early detection of colorectal cancers and polyps: summary of evidence-based analyses.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2009-09-01

Review 6.  Colorectal cancer: CT colonography and colonoscopy for detection--systematic review and meta-analysis.

Authors:  Perry J Pickhardt; Cesare Hassan; Steve Halligan; Riccardo Marmo
Journal:  Radiology       Date:  2011-03-17       Impact factor: 11.105

7.  Extracolonic findings at computed tomography colonography are a challenge.

Authors:  B Ginnerup Pedersen; M Rosenkilde; T E M Christiansen; S Laurberg
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

Review 8.  Virtual colonoscopy for colorectal cancer screening: current status.

Authors:  Jay P Heiken; Christine M Peterson; Christine O Menias
Journal:  Cancer Imaging       Date:  2005-11-23       Impact factor: 3.909

Review 9.  Can Computed Tomography Colonography Replace Optical Colonoscopy in Detecting Colorectal Lesions?: State of the Art.

Authors:  Alessia Chini; Michele Manigrasso; Grazia Cantore; Rosa Maione; Marco Milone; Francesco Maione; Giovanni Domenico De Palma
Journal:  Clin Endosc       Date:  2022-02-24

Review 10.  Developments in Screening Tests and Strategies for Colorectal Cancer.

Authors:  Justin L Sovich; Zachary Sartor; Subhasis Misra
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.